ICOS-L as a Potential Therapeutic Target for Cancer Immunotherapy.

CONCLUSION: ICOS/ICOS-L signal pathway has the potential to improve cancer treatment. However, studies in other models are needed to understand whether inhibition of ICOS expression or the blockage of its co-stimulation could be a potential therapeutic target or adjuvant treatment for immunotherapy. PMID: 29879883 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29879883?dopt=Abstract

Source: Current Protein and Peptide Science - June 7, 2018 Category: Biochemistry Authors: Oliviero M, Massimo N, Beatrice MM, Luciana T, Consuelo A, Giorgio S Tags: Curr Protein Pept Sci Source Type: research